← Back to Search

Radiography System

Breast biopsy specimen imaging & comparison of image quality for Breast Cancer

N/A
Waitlist Available
Led By Gary M. Levine, M.D.
Research Sponsored by Levine, Gary M. , M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Breast specimens acquired through MIBB or Surgical techniques arriving for specimen imaging
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

The objective of this study is to evaluate the image quality and operation of a self-contained direct digital radiography system for breast specimen imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Breast biopsy specimen will be imaged on standard of care device and on the Trident Specimen Radiography device to compare quality of images.
Secondary outcome measures
Device Operation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Breast biopsy specimen imaging & comparison of image qualityExperimental Treatment2 Interventions
Each subject's explanted tissue will serve as both the control (standard analysis) and the experimental analysis of the quality of the images.

Find a Location

Who is running the clinical trial?

Hologic, Inc.Industry Sponsor
46 Previous Clinical Trials
60,007 Total Patients Enrolled
13 Trials studying Breast Cancer
17,486 Patients Enrolled for Breast Cancer
Levine, Gary M. , M.D.Lead Sponsor
Gary M. Levine, M.D.Principal InvestigatorHoag Memorial Hospital Presbyterian

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025